Revolutionary tech at Heart Institute conquers high blood pressure

1 min read

TLDR: The Stony Brook Heart Institute at Stony Brook University Hospital has become among the first in the nation to perform ultrasound renal denervation, a minimally invasive technique to treat high blood pressure in patients with resistant hypertension. Resistant hypertension is a form of elevated blood pressure that does not respond to lifestyle changes or medication. The new technology involves using ultrasound energy in the renal artery to ablate the nerves that run just outside the artery, thus bringing the blood pressure under better control. The FDA approved this technology, called the Paradise Ultrasound Renal Denervation system, on November 7. The Stony Brook Heart Institute is the first on Long Island to use this technology and was one of the centers that participated in the RADIANCE CAP trial that demonstrated the safety and effectiveness of the treatment

Previous Story

Apple’s stealthy stockpiling fuels its AI boom and talent quest.

Next Story

Embroker: One Platform, Infinite Possibilities for Professional Financial Services Coverage

Latest from News